These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15902352)

  • 1. The evolution of positron emission tomography.
    Ho GC
    Singapore Med J; 2005 Jun; 46(6):257-8. PubMed ID: 15902352
    [No Abstract]   [Full Text] [Related]  

  • 2. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans.
    van Tol KM; Jager PL; Dullaart RP; Links TP
    J Clin Endocrinol Metab; 2000 May; 85(5):2082-3. PubMed ID: 10843201
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma.
    Nahas Z; Goldenberg D; Fakhry C; Ewertz M; Zeiger M; Ladenson PW; Wahl R; Tufano RP
    Laryngoscope; 2005 Feb; 115(2):237-43. PubMed ID: 15689742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
    Laking GR; Price PM
    J Nucl Med; 2002 Dec; 43(12):1728-9; author reply 1729. PubMed ID: 12468527
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of positron emission tomography scanning in patients with radioactive iodine scan-negative, recurrent differentiated thyroid cancer.
    Roberts M; Maghami E; Kandeel F; Yamauchi D; Ellenhorn HL; Ellenhorn JD
    Am Surg; 2007 Oct; 73(10):1052-6. PubMed ID: 17983080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
    Robbins RJ; Wan Q; Grewal RK; Reibke R; Gonen M; Strauss HW; Tuttle RM; Drucker W; Larson SM
    J Clin Endocrinol Metab; 2006 Feb; 91(2):498-505. PubMed ID: 16303836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan].
    Cabrera Martín MN; Pasamontes Pingarrón JA; Carreras Delgado JL; Lapeña Gutiérrez L; Delgado Bolton RC; Bittini Copano A; Pérez Castejón MJ; Fernández Pérez C
    Rev Esp Med Nucl; 2007; 26(5):263-9. PubMed ID: 17910834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
    Razfar A; Branstetter BF; Christopoulos A; Lebeau SO; Hodak SP; Heron DE; Escott EJ; Ferris RL
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):120-5. PubMed ID: 20157055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.
    David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC
    Thyroid; 2005 Mar; 15(3):267-73. PubMed ID: 15785246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
    Ong SC; Ng DC; Sundram FX
    Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G; Possa M; Sara R; Milella M; Rossetti C
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
    Zuijdwijk MD; Vogel WV; Corstens FH; Oyen WJ
    Nucl Med Commun; 2008 Jul; 29(7):636-41. PubMed ID: 18528186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
    Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
    In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
    Schlumberger M
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):119-20. PubMed ID: 15670184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
    Mariscal Labrador E; García Burillo A; Castell-Conesa J; Obiols Alfonso G; Kisiel González N; Barios Profitós M; Aguadé-Bruix S; Mesa Manteca J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):146-51. PubMed ID: 22726673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of serum thyroglobulin assays in cancers of the thyroid].
    Schlumberger M; Fragu P; Travagli JP; Gardet P; Lumbroso J; Charbord P; Lacour J; Parmentier C
    Nouv Presse Med; 1982 Oct; 11(42):3101-5. PubMed ID: 7177824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.